CLOFAZIMINE

CLOFAZIMINE was reported 6489 times

CLOFAZIMINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CILIARY ZONULAR WEAKNESS 5 0.7143
1 ANTIMICROBIAL SUSCEPTIBILITY TEST INTERMEDIATE 6 0.5455
2 TYPE 2 LEPRA REACTION 88 0.4706
3 TYPE 1 LEPRA REACTION 16 0.3137
4 BECKWITH-WIEDEMANN SYNDROME 3 0.2143
5 HERBAL TOXICITY 6 0.2000
6 BENIGN SOFT TISSUE NEOPLASM 7 0.1842
7 LEPROMATOUS LEPROSY 13 0.1529
8 TUBERCULOID LEPROSY 8 0.1231
9 MYCOBACTERIUM ABSCESSUS INFECTION 75 0.1049
10 TOXIC OPTIC NEUROPATHY 37 0.0853
11 MYCOBACTERIAL PERITONITIS 8 0.0842
12 MYCOBACTERIUM FORTUITUM INFECTION 15 0.0811
13 ATYPICAL MYCOBACTERIUM TEST POSITIVE 7 0.0722
14 MYCOBACTERIUM HAEMOPHILUM INFECTION 19 0.0664
15 IMMUNOSUPPRESSANT DRUG LEVEL ABNORMAL 4 0.0606
16 CEREBROVASCULAR ARTERIOVENOUS MALFORMATION 5 0.0575
17 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 12 0.0543
18 HISTIOCYTOSIS 7 0.0526
19 AIDS RELATED COMPLICATION 3 0.0462
20 ICHTHYOSIS 11 0.0437
21 PYELONEPHRITIS CHRONIC 8 0.0426
22 MYCOBACTERIUM AVIUM COMPLEX INFECTION 109 0.0406
23 OTOTOXICITY 74 0.0400
24 URINARY TRACT INFLAMMATION 13 0.0361
25 SIDEROBLASTIC ANAEMIA 5 0.0357
26 CYSTIC LUNG DISEASE 5 0.0352
27 MYCOBACTERIUM TEST POSITIVE 7 0.0340
28 BRONCHOPLEURAL FISTULA 12 0.0319
29 COR PULMONALE CHRONIC 6 0.0319
30 CONDUCTIVE DEAFNESS 10 0.0312
31 ACID FAST BACILLI INFECTION 5 0.0311
32 MENINGITIS TUBERCULOUS 17 0.0304
33 OPTIC NEUROPATHY 64 0.0302
34 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 10 0.0299
35 LEPROSY 6 0.0288
36 ATYPICAL MYCOBACTERIAL PNEUMONIA 4 0.0288
37 INTRACARDIAC MASS 5 0.0282
38 PSOAS ABSCESS 17 0.0273
39 INFECTIVE EXACERBATION OF BRONCHIECTASIS 8 0.0261
40 VENTRICULAR DYSKINESIA 5 0.0240
41 CHRONIC HEPATITIS C 9 0.0228
42 MYCOBACTERIAL INFECTION 39 0.0226
43 CYTOKINE INCREASED 3 0.0222
44 TUBERCULOMA OF CENTRAL NERVOUS SYSTEM 4 0.0220
45 HEPATITIS B SURFACE ANTIGEN POSITIVE 6 0.0219
46 MYCOBACTERIUM CHELONAE INFECTION 16 0.0217
47 ELECTROCARDIOGRAM QT PROLONGED 767 0.0213
48 BONE TUBERCULOSIS 8 0.0209
49 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 8 0.0197
50 ACOUSTIC NEUROMA 8 0.0196
51 DEAFNESS NEUROSENSORY 64 0.0194
52 ATYPICAL MYCOBACTERIAL INFECTION 27 0.0191
53 PULMONARY CAVITATION 16 0.0184
54 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 5 0.0184
55 DOSING ERROR 3 0.0179
56 TOXIC NEUROPATHY 7 0.0178
57 VASCULAR ENCEPHALOPATHY 5 0.0176
58 SPUTUM CULTURE POSITIVE 14 0.0172
59 MACROCEPHALY 6 0.0155
60 CARDIAC NEOPLASM UNSPECIFIED 3 0.0150
61 DEPOSIT EYE 4 0.0149
62 CHRONIC RESPIRATORY FAILURE 18 0.0149
63 CARBON MONOXIDE POISONING 6 0.0140
64 PULMONARY TUBERCULOSIS 58 0.0136
65 NEUROPSYCHOLOGICAL SYMPTOMS 8 0.0133
66 VESTIBULAR DISORDER 16 0.0131
67 CEREBRAL MICROANGIOPATHY 3 0.0126
68 ELECTROLYTE DEPLETION 6 0.0122
69 PNEUMOTHORAX SPONTANEOUS 8 0.0118
70 CARDIOPULMONARY FAILURE 45 0.0115
71 COR PULMONALE 11 0.0115
72 HEPATITIS TOXIC 28 0.0107
73 DRUG RESISTANCE 272 0.0106
74 CATARACT OPERATION COMPLICATION 5 0.0098
75 TRICHOGLOSSIA 4 0.0098
76 NEURITIS 15 0.0097
77 ALCOHOL POISONING 26 0.0097
78 DISSEMINATED TUBERCULOSIS 24 0.0093
79 BICYTOPENIA 18 0.0092
80 DISCONTINUED PRODUCT ADMINISTERED 3 0.0091
81 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 7 0.0090
82 NEUROPSYCHIATRIC SYMPTOMS 8 0.0089
83 BRONCHIECTASIS 58 0.0086
84 INFECTIOUS PLEURAL EFFUSION 13 0.0085
85 HEPATITIS C VIRUS TEST POSITIVE 5 0.0085
86 CORONARY ARTERY INSUFFICIENCY 3 0.0084
87 HEPATOTOXICITY 186 0.0083
88 ABSCESS BACTERIAL 3 0.0083
89 GASTROINTESTINAL TRACT ADENOMA 3 0.0082
90 HELICOBACTER GASTRITIS 10 0.0081
91 STEROID DEPENDENCE 7 0.0080
92 HIV INFECTION 24 0.0080
93 HYPERSENSITIVITY PNEUMONITIS 9 0.0079
94 FIBROMA 7 0.0076
95 PRETERM PREMATURE RUPTURE OF MEMBRANES 9 0.0075
96 PATHOGEN RESISTANCE 68 0.0075
97 SPUTUM INCREASED 16 0.0074
98 OPTIC NEURITIS 67 0.0074
99 SKIN HYPERPIGMENTATION 63 0.0073
100 GLUCOCORTICOID DEFICIENCY 3 0.0071
101 DEAFNESS BILATERAL 12 0.0071
102 BLOOD MAGNESIUM INCREASED 6 0.0067
103 HEPATORENAL FAILURE 4 0.0066
104 CEREBRAL MICROHAEMORRHAGE 3 0.0066
105 BLOOD BILIRUBIN DECREASED 4 0.0065
106 MULTIPLE-DRUG RESISTANCE 20 0.0064
107 POLYNEUROPATHY 76 0.0063
108 OCULAR TOXICITY 7 0.0063
109 GRAFT VERSUS HOST DISEASE IN LUNG 3 0.0063
110 EYELID RASH 6 0.0061
111 MITOCHONDRIAL TOXICITY 5 0.0061
112 SPUTUM PURULENT 4 0.0061
113 SPUTUM ABNORMAL 4 0.0060
114 DYSCHROMATOPSIA 5 0.0060
115 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 3 0.0060
116 POST PROCEDURAL DISCHARGE 4 0.0059
117 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 29 0.0058
118 ELECTROCARDIOGRAM T WAVE ABNORMAL 9 0.0058
119 BLOOD CREATININE DECREASED 18 0.0057
120 FALSE NEGATIVE INVESTIGATION RESULT 4 0.0057
121 BILIRUBIN CONJUGATED INCREASED 13 0.0056
122 ALANINE AMINOTRANSFERASE DECREASED 4 0.0055
123 TOOTH DISCOLOURATION 16 0.0054
124 VARICELLA ZOSTER VIRUS INFECTION 11 0.0053
125 STENOTROPHOMONAS INFECTION 7 0.0052
126 EXTRADURAL ABSCESS 4 0.0051
127 DUODENAL PERFORATION 5 0.0051
128 ANTISOCIAL BEHAVIOUR 5 0.0050
129 LONG QT SYNDROME 12 0.0050
130 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 6 0.0050
131 OPTIC NERVE DISORDER 8 0.0050
132 LUNG OPACITY 13 0.0049
133 XEROSIS 6 0.0048
134 RESPIRATORY TRACT IRRITATION 5 0.0048
135 CONCOMITANT DISEASE AGGRAVATED 29 0.0047
136 DRUG-INDUCED LIVER INJURY 147 0.0047
137 BLOOD CHLORIDE DECREASED 12 0.0046
138 ORCHITIS 5 0.0046
139 NODAL ARRHYTHMIA 4 0.0046
140 ABDOMINAL WALL ABSCESS 3 0.0046
141 BLOOD CHLORIDE INCREASED 8 0.0046
142 WOUND INFECTION STAPHYLOCOCCAL 8 0.0046
143 PNEUMONIA STREPTOCOCCAL 5 0.0046
144 HERPES OPHTHALMIC 6 0.0045
145 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 115 0.0045
146 RIGHT VENTRICULAR HYPERTROPHY 4 0.0044
147 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 24 0.0044
148 PHOBIA 5 0.0044
149 COMPUTERISED TOMOGRAM THORAX ABNORMAL 3 0.0044
150 PARADOXICAL DRUG REACTION 16 0.0043
151 HEPATITIS CHOLESTATIC 26 0.0043
152 ELECTROLYTE IMBALANCE 50 0.0043
153 HAEMOPTYSIS 120 0.0043
154 OPTIC ATROPHY 7 0.0043
155 GRANULOMATOUS LIVER DISEASE 3 0.0043
156 INTRACRANIAL MASS 4 0.0042
157 NEUROPATHY PERIPHERAL 392 0.0041
158 ALCOHOL ABUSE 11 0.0041
159 HYPERLACTACIDAEMIA 11 0.0041
160 HYPERTRIGLYCERIDAEMIA 24 0.0041
161 INCORRECT PRODUCT ADMINISTRATION DURATION 88 0.0041
162 BLOOD ELECTROLYTES ABNORMAL 5 0.0040
163 SPUTUM RETENTION 4 0.0040
164 HYPOFIBRINOGENAEMIA 4 0.0040
165 CORNEAL DEPOSITS 3 0.0040
166 BUTTERFLY RASH 4 0.0039
167 PNEUMONIA PSEUDOMONAL 6 0.0039
168 BLOOD ALBUMIN DECREASED 31 0.0039
169 MEAN CELL VOLUME DECREASED 6 0.0039
170 ADJUSTMENT DISORDER 5 0.0038
171 IRIDOCYCLITIS 12 0.0038
172 PIGMENTATION DISORDER 23 0.0037
173 TOXOPLASMOSIS 4 0.0037
174 CHRONIC HEPATITIS 3 0.0037
175 DEAFNESS 96 0.0037
176 OSTEOPOROTIC FRACTURE 7 0.0037
177 RIGHT VENTRICULAR DYSFUNCTION 4 0.0036
178 LIGAMENT INJURY 4 0.0035
179 LICHENOID KERATOSIS 8 0.0035
180 HEPATIC HAEMORRHAGE 3 0.0035
181 CARDIAC FAILURE ACUTE 23 0.0034
182 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
183 OSTEOCHONDROSIS 4 0.0034
184 CYSTIC FIBROSIS 19 0.0034
185 FANCONI SYNDROME ACQUIRED 6 0.0034
186 HYPERURICAEMIA 14 0.0034
187 PNEUMOTHORAX 54 0.0034
188 NEPHROPATHY TOXIC 38 0.0034
189 DRUG LEVEL FLUCTUATING 3 0.0034
190 PANCREATITIS CHRONIC 8 0.0034
191 CACHEXIA 17 0.0033
192 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
193 DRUG LEVEL ABOVE THERAPEUTIC 15 0.0033
194 COLOUR BLINDNESS 3 0.0033
195 SUPRAVENTRICULAR EXTRASYSTOLES 11 0.0033
196 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
197 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0032
198 CEREBRAL TOXOPLASMOSIS 3 0.0032
199 GRANULOMA 11 0.0032
200 PNEUMONIA BACTERIAL 29 0.0032
201 MALNUTRITION 35 0.0031
202 HAEMOLYTIC ANAEMIA 28 0.0031
203 DYSPNOEA AT REST 9 0.0031
204 STRONGYLOIDIASIS 5 0.0031
205 CARDIOVASCULAR INSUFFICIENCY 5 0.0031
206 DUST ALLERGY 3 0.0031
207 FACIAL PARALYSIS 26 0.0030
208 ASPARTATE AMINOTRANSFERASE INCREASED 161 0.0030
209 EMPYEMA 6 0.0030
210 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 5 0.0030
211 HYPERCAPNIA 9 0.0030
212 TRANSAMINASES INCREASED 66 0.0030
213 VULVOVAGINAL CANDIDIASIS 4 0.0030
214 HYDROCEPHALUS 16 0.0029
215 DUODENITIS 9 0.0029
216 HEPATIC NECROSIS 11 0.0029
217 BLOOD SODIUM DECREASED 55 0.0029
218 BLOOD MAGNESIUM DECREASED 25 0.0029
219 INTRACRANIAL PRESSURE INCREASED 16 0.0029
220 PERIPHERAL MOTOR NEUROPATHY 4 0.0029
221 RESPIRATORY SYMPTOM 8 0.0028
222 HYPOMAGNESAEMIA 39 0.0028
223 MENINGITIS BACTERIAL 4 0.0028
224 VASCULAR INJURY 4 0.0028
225 PNEUMOMEDIASTINUM 5 0.0028
226 EXPOSURE VIA BREAST MILK 11 0.0028
227 BLOOD CALCIUM DECREASED 31 0.0028
228 ACARODERMATITIS 3 0.0027
229 SPUTUM DISCOLOURED 26 0.0027
230 ELECTROCARDIOGRAM T WAVE INVERSION 6 0.0027
231 AMYLASE INCREASED 10 0.0027
232 FAILURE TO THRIVE 14 0.0027
233 SKIN STRIAE 4 0.0027
234 MIXED LIVER INJURY 8 0.0027
235 CHRONIC GASTRITIS 6 0.0027
236 SUSPECTED OFF LABEL USE 12 0.0027
237 MARASMUS 4 0.0026
238 BLOOD FIBRINOGEN DECREASED 3 0.0026
239 HYPOKALAEMIA 121 0.0026
240 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 4 0.0026
241 CARBON DIOXIDE DECREASED 3 0.0026
242 METHAEMOGLOBINAEMIA 6 0.0026
243 ASPERGILLUS INFECTION 17 0.0026
244 SKIN DISCOLOURATION 119 0.0026
245 HYPERTRANSAMINASAEMIA 18 0.0026
246 OCULAR HYPERTENSION 5 0.0026
247 HYPOALBUMINAEMIA 20 0.0026
248 PERIPHERAL SENSORY NEUROPATHY 15 0.0026
249 CONCOMITANT DISEASE PROGRESSION 5 0.0026
250 TORSADE DE POINTES 20 0.0025
251 ANAEMIA 486 0.0025
252 ALANINE AMINOTRANSFERASE INCREASED 154 0.0025
253 MYELOSUPPRESSION 90 0.0025
254 DEVICE RELATED SEPSIS 5 0.0025
255 FOETAL GROWTH RESTRICTION 15 0.0025
256 GASTROENTERITIS 36 0.0025
257 OXYGEN THERAPY 4 0.0024
258 ORAL CANDIDIASIS 32 0.0024
259 HEPATITIS 62 0.0024
260 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
261 DERMATITIS EXFOLIATIVE 12 0.0024
262 RESPIRATORY FAILURE 173 0.0024
263 DEAFNESS UNILATERAL 13 0.0024
264 TORTICOLLIS 5 0.0024
265 ACIDOSIS 18 0.0024
266 NOCARDIOSIS 6 0.0023
267 HEPATOSPLENOMEGALY 6 0.0023
268 AORTIC ARTERIOSCLEROSIS 6 0.0023
269 TINNITUS 107 0.0023
270 IRITIS 7 0.0023
271 HENOCH-SCHONLEIN PURPURA 5 0.0023
272 PORTAL HYPERTENSION 7 0.0023
273 CLOSTRIDIUM DIFFICILE COLITIS 24 0.0023
274 TRANSPLANT REJECTION 18 0.0022
275 MENINGITIS 15 0.0022
276 CARBON DIOXIDE INCREASED 3 0.0022
277 ARTHRITIS BACTERIAL 9 0.0022
278 TYPE IV HYPERSENSITIVITY REACTION 6 0.0022
279 VENTRICULAR ARRHYTHMIA 8 0.0022
280 SOFT TISSUE INFECTION 4 0.0022
281 AUTISM SPECTRUM DISORDER 12 0.0022
282 PNEUMONIA KLEBSIELLA 4 0.0022
283 PLEURITIC PAIN 6 0.0022
284 BRONCHIAL OBSTRUCTION 3 0.0021
285 FANCONI SYNDROME 3 0.0021
286 LYMPHOPENIA 30 0.0021
287 HEPATIC CYTOLYSIS 27 0.0021
288 AUDITORY DISORDER 3 0.0021
289 BLOOD BICARBONATE DECREASED 4 0.0021
290 HYPOPROTEINAEMIA 4 0.0021
291 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
292 PULMONARY FUNCTION TEST DECREASED 9 0.0021
293 PULMONARY PAIN 6 0.0021
294 AUTONOMIC NERVOUS SYSTEM IMBALANCE 6 0.0021
295 HYPERAEMIA 4 0.0020
296 UNDERWEIGHT 4 0.0020
297 HEPATITIS FULMINANT 6 0.0020
298 METABOLIC ENCEPHALOPATHY 6 0.0020
299 PLATELET COUNT INCREASED 26 0.0020
300 TOXIC SKIN ERUPTION 20 0.0020
301 BRAIN ABSCESS 5 0.0020
302 HEPATOCELLULAR INJURY 28 0.0020
303 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 12 0.0020
304 CHEST INJURY 4 0.0019
305 HYPERBILIRUBINAEMIA 20 0.0019
306 PSYCHOTIC DISORDER 57 0.0019
307 SKIN NECROSIS 10 0.0019
308 LUNG ABSCESS 4 0.0019
309 PRODUCTIVE COUGH 91 0.0019
310 HYPOVOLAEMIC SHOCK 9 0.0019
311 CUSHINGOID 6 0.0019
312 PSEUDOMONAS INFECTION 16 0.0019
313 LIP BLISTER 5 0.0018
314 BLOOD PHOSPHORUS INCREASED 5 0.0018
315 HYPOTHYROIDISM 58 0.0018
316 NOSOCOMIAL INFECTION 4 0.0018
317 GAMMA-GLUTAMYLTRANSFERASE INCREASED 40 0.0018
318 RASH MORBILLIFORM 5 0.0018
319 PAPILLOEDEMA 8 0.0018
320 ACUTE RESPIRATORY FAILURE 34 0.0018
321 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
322 FORCED EXPIRATORY VOLUME DECREASED 5 0.0018
323 TREATMENT FAILURE 146 0.0018
324 BLOOD DISORDER 14 0.0017
325 DENGUE FEVER 4 0.0017
326 VENTRICULAR EXTRASYSTOLES 18 0.0017
327 BLOOD ALKALINE PHOSPHATASE INCREASED 43 0.0017
328 HEPATOMEGALY 17 0.0017
329 LYMPHOPROLIFERATIVE DISORDER 5 0.0017
330 INTENTIONAL PRODUCT USE ISSUE 149 0.0017
331 LIPASE INCREASED 13 0.0017
332 HYPOACUSIS 73 0.0017
333 HYPOCALCAEMIA 32 0.0017
334 ATYPICAL PNEUMONIA 5 0.0017
335 GASTROINTESTINAL TOXICITY 8 0.0017
336 LYMPHADENITIS 4 0.0017
337 CHOLECYSTITIS CHRONIC 11 0.0016
338 CARDIAC FAILURE CHRONIC 7 0.0016
339 PROTEIN TOTAL DECREASED 6 0.0016
340 HYPOGAMMAGLOBULINAEMIA 10 0.0015
341 GENE MUTATION 3 0.0015
342 SUDDEN DEATH 16 0.0015
343 LIVER FUNCTION TEST INCREASED 32 0.0015
344 EOSINOPHILIA 26 0.0015
345 GASTRITIS 39 0.0015
346 EAR CONGESTION 4 0.0015
347 BONE MARROW FAILURE 30 0.0015
348 LACTIC ACIDOSIS 47 0.0014
349 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 75 0.0014
350 IMMUNE THROMBOCYTOPENIC PURPURA 4 0.0014
351 PULMONARY MASS 21 0.0014
352 HEPATITIS C 17 0.0014
353 DRUG INTOLERANCE 136 0.0014
354 PNEUMATOSIS INTESTINALIS 4 0.0014
355 HAEMOGLOBIN DECREASED 144 0.0014
356 LEFT VENTRICULAR HYPERTROPHY 6 0.0014
357 SKIN ATROPHY 8 0.0014
358 EMPHYSEMA 14 0.0014
359 HEPATITIS ACUTE 9 0.0014
360 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
361 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
362 RALES 8 0.0014
363 SPONDYLITIS 5 0.0014
364 BLOOD BILIRUBIN INCREASED 37 0.0014
365 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 3 0.0014
366 CARDIOMYOPATHY 20 0.0014
367 SINUS BRADYCARDIA 13 0.0013
368 PARTIAL SEIZURES 7 0.0013
369 NORMOCHROMIC NORMOCYTIC ANAEMIA 4 0.0013
370 GENERALISED TONIC-CLONIC SEIZURE 22 0.0013
371 BLOOD LACTIC ACID INCREASED 7 0.0013
372 NEPHROTIC SYNDROME 9 0.0013
373 BRONCHOPULMONARY ASPERGILLOSIS 10 0.0013
374 PERITONITIS BACTERIAL 13 0.0013
375 ARRHYTHMIA 61 0.0013
376 EPIGASTRIC DISCOMFORT 5 0.0013
377 PULMONARY HAEMORRHAGE 10 0.0013
378 SWELLING OF EYELID 8 0.0013
379 DISTURBANCE IN SOCIAL BEHAVIOUR 3 0.0013
380 RESPIRATORY ACIDOSIS 5 0.0013
381 LEUKOCYTOSIS 23 0.0013
382 COVID-19 PNEUMONIA 15 0.0013
383 PANCYTOPENIA 71 0.0013
384 BLOOD POTASSIUM DECREASED 38 0.0013
385 BRONCHOSPASM 18 0.0013
386 EOSINOPHIL COUNT DECREASED 3 0.0013
387 TRICUSPID VALVE INCOMPETENCE 10 0.0013
388 OESOPHAGEAL CANDIDIASIS 5 0.0013
389 CHOLECYSTITIS ACUTE 7 0.0012
390 RESPIRATORY DISTRESS 34 0.0012
391 MYOCARDIAL ISCHAEMIA 14 0.0012
392 JAUNDICE 33 0.0012
393 HYPERAESTHESIA 10 0.0012
394 OTITIS MEDIA 4 0.0012
395 PEPTIC ULCER 4 0.0012
396 WHITE BLOOD CELL COUNT INCREASED 46 0.0012
397 BLOOD UREA INCREASED 20 0.0012
398 WOUND DEHISCENCE 4 0.0012
399 GASTROINTESTINAL DISORDER 106 0.0012
400 BUNDLE BRANCH BLOCK LEFT 5 0.0012
401 PLEURISY 7 0.0012
402 HEPATIC ENZYME INCREASED 80 0.0012
403 PURULENT DISCHARGE 5 0.0012
404 TREATMENT NONCOMPLIANCE 64 0.0012
405 EAR DISCOMFORT 12 0.0012
406 PRODUCT USE IN UNAPPROVED INDICATION 286 0.0012
407 BLOOD CREATININE INCREASED 75 0.0011
408 ELECTROCARDIOGRAM ABNORMAL 9 0.0011
409 DYSPHONIA 67 0.0011
410 TONGUE DISCOLOURATION 5 0.0011
411 LOW BIRTH WEIGHT BABY 9 0.0011
412 LUNG TRANSPLANT 4 0.0011
413 BLOOD CREATINE INCREASED 5 0.0011
414 ABDOMINAL MASS 3 0.0011
415 RED BLOOD CELL COUNT DECREASED 32 0.0011
416 IRON DEFICIENCY 5 0.0011
417 DERMATITIS BULLOUS 8 0.0011
418 DEVICE RELATED INFECTION 17 0.0011
419 GASTRIC PERFORATION 3 0.0011
420 INTESTINAL ISCHAEMIA 6 0.0011
421 DYSPNOEA EXERTIONAL 41 0.0011
422 BLOOD THYROID STIMULATING HORMONE INCREASED 10 0.0011
423 VOMITING 507 0.0011
424 APHONIA 15 0.0011
425 PANCREATITIS ACUTE 24 0.0011
426 THROMBOCYTOPENIA 117 0.0010
427 CHOLESTASIS 20 0.0010
428 PANCREATITIS 55 0.0010
429 ADENOVIRUS INFECTION 3 0.0010
430 RASH VESICULAR 5 0.0010
431 LEUKOPENIA 51 0.0010
432 VENOUS THROMBOSIS 4 0.0010
433 NAIL DISCOLOURATION 4 0.0010
434 PANCREATIC DISORDER 5 0.0010
435 HAEMATOCRIT DECREASED 20 0.0010
436 COUGH 282 0.0010
437 METABOLIC ACIDOSIS 32 0.0010
438 RIGHT VENTRICULAR FAILURE 7 0.0010
439 HEPATITIS B 6 0.0010
440 HYPOXIA 35 0.0010
441 PAPULE 7 0.0010
442 DRUG TOLERANCE 5 0.0010
443 BLOOD POTASSIUM INCREASED 16 0.0010
444 DYSAESTHESIA 3 0.0010
445 DECREASED APPETITE 227 0.0010
446 NEUTROPHIL COUNT INCREASED 10 0.0010
447 FIBROSIS 3 0.0010
448 IRON DEFICIENCY ANAEMIA 9 0.0010
449 ANAPHYLACTOID REACTION 4 0.0010
450 OLIGURIA 6 0.0010
451 LIVER FUNCTION TEST ABNORMAL 28 0.0010
452 FAECES SOFT 7 0.0010
453 INCORRECT DRUG ADMINISTRATION DURATION 27 0.0010
454 SECRETION DISCHARGE 12 0.0010
455 DRUG INTERACTION 151 0.0010
456 CANDIDA INFECTION 16 0.0009
457 ATELECTASIS 9 0.0009
458 ACUTE KIDNEY INJURY 142 0.0009
459 ANTINUCLEAR ANTIBODY POSITIVE 3 0.0009
460 SKIN REACTION 13 0.0009
461 OCULAR ICTERUS 4 0.0009
462 BACTERIAL SEPSIS 3 0.0009
463 NORMAL NEWBORN 5 0.0009
464 NODULE 12 0.0009
465 REFUSAL OF TREATMENT BY PATIENT 6 0.0009
466 LUNG DISORDER 45 0.0009
467 MULTIPLE ORGAN DYSFUNCTION SYNDROME 26 0.0009
468 AGRANULOCYTOSIS 17 0.0009
469 NEUROTOXICITY 16 0.0009
470 SKIN LESION 25 0.0009
471 LUNG INFILTRATION 8 0.0009
472 NECROSIS 5 0.0009
473 TACHYPNOEA 12 0.0009
474 NEUTROPHILIA 5 0.0009
475 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
476 ISCHAEMIA 4 0.0009
477 PULMONARY EMBOLISM 82 0.0009
478 HALLUCINATION, VISUAL 18 0.0009
479 VAGINAL INFECTION 4 0.0008
480 TENDONITIS 13 0.0008
481 ODYNOPHAGIA 5 0.0008
482 VISUAL FIELD DEFECT 6 0.0008
483 OFF LABEL USE 722 0.0008
484 OESOPHAGITIS 9 0.0008
485 DERMATITIS ACNEIFORM 5 0.0008
486 RENAL IMPAIRMENT 69 0.0008
487 ABDOMINAL TENDERNESS 4 0.0008
488 PNEUMOCYSTIS JIROVECII PNEUMONIA 8 0.0008
489 DERMATITIS ALLERGIC 10 0.0008
490 HYPOTHERMIA 8 0.0008
491 RESPIRATORY RATE INCREASED 7 0.0008
492 PHOTOSENSITIVITY REACTION 13 0.0008
493 CARDIOTOXICITY 7 0.0008
494 ATRIOVENTRICULAR BLOCK 6 0.0008
495 NIGHT SWEATS 25 0.0008
496 SINUS TACHYCARDIA 11 0.0008
497 TENDON DISORDER 5 0.0008
498 MALABSORPTION 4 0.0008
499 MENTAL DISORDER 33 0.0008
500 ARTERIOSCLEROSIS CORONARY ARTERY 5 0.0008
501 CEREBRAL ATROPHY 3 0.0008
502 ATRIAL FLUTTER 6 0.0008
503 SKIN MASS 5 0.0007
504 CANDIDIASIS 3 0.0007
505 HYPOPHAGIA 19 0.0007
506 ADRENAL INSUFFICIENCY 9 0.0007
507 SHOCK 17 0.0007
508 CYTOPENIA 9 0.0007
509 PRODUCT PRESCRIBING ISSUE 16 0.0007
510 DRUG ERUPTION 13 0.0007
511 LIVER INJURY 18 0.0007
512 EYE MOVEMENT DISORDER 5 0.0007
513 SEROTONIN SYNDROME 14 0.0007
514 HYPONATRAEMIA 41 0.0007
515 GENERALISED OEDEMA 9 0.0007
516 RESPIRATION ABNORMAL 5 0.0007
517 DRUG LEVEL BELOW THERAPEUTIC 4 0.0007
518 HYPERKERATOSIS 4 0.0007
519 DYSPNOEA 409 0.0007
520 NAUSEA 571 0.0007
521 HEMIPLEGIA 6 0.0007
522 EOSINOPHIL COUNT INCREASED 6 0.0007
523 RASH MACULO-PAPULAR 16 0.0007
524 AUTOIMMUNE HEPATITIS 5 0.0007
525 THERAPY INTERRUPTED 51 0.0007
526 HALLUCINATIONS, MIXED 3 0.0007
527 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 39 0.0007
528 HEPATIC FAILURE 21 0.0007
529 HEPATIC CIRRHOSIS 13 0.0007
530 ABSCESS 11 0.0007
531 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
532 URINE OUTPUT DECREASED 6 0.0007
533 HYPOPHOSPHATAEMIA 5 0.0007
534 ATAXIA 8 0.0007
535 PYREXIA 232 0.0007
536 INTENTIONAL DOSE OMISSION 19 0.0007
537 WEIGHT DECREASED 186 0.0007
538 BLOOD PRESSURE DECREASED 44 0.0007
539 GASTROINTESTINAL CARCINOMA 6 0.0007
540 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
541 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
542 ACUTE HEPATIC FAILURE 9 0.0007
543 SEIZURE 76 0.0007
544 HAEMOGLOBIN INCREASED 3 0.0007
545 PLATELET COUNT DECREASED 70 0.0007
546 EAR DISORDER 3 0.0007
547 DISEASE RECURRENCE 31 0.0007
548 ARTHRITIS INFECTIVE 3 0.0006
549 DEEP VEIN THROMBOSIS 42 0.0006
550 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
551 FLANK PAIN 6 0.0006
552 NEUTROPENIA 87 0.0006
553 HYPOGLYCAEMIA 31 0.0006
554 SQUAMOUS CELL CARCINOMA 6 0.0006
555 HAEMATOTOXICITY 6 0.0006
556 NASAL DISCOMFORT 5 0.0006
557 ENTERITIS 4 0.0006
558 DISEASE PROGRESSION 73 0.0006
559 HERPES SIMPLEX 4 0.0006
560 ASCITES 18 0.0006
561 HICCUPS 5 0.0006
562 OSTEOMYELITIS 11 0.0006
563 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 5 0.0006
564 FOETAL EXPOSURE DURING PREGNANCY 49 0.0006
565 HEPATIC ENZYME ABNORMAL 3 0.0006
566 ATRIAL SEPTAL DEFECT 5 0.0006
567 CARDIAC ARREST 49 0.0006
568 SKIN PLAQUE 5 0.0006
569 HAEMATEMESIS 15 0.0006
570 BACTERAEMIA 7 0.0006
571 GENERAL PHYSICAL HEALTH DETERIORATION 68 0.0006
572 ENDOCARDITIS 3 0.0006
573 PYELONEPHRITIS 5 0.0006
574 ABDOMINAL PAIN 134 0.0006
575 TENDERNESS 6 0.0006
576 SEPTIC SHOCK 25 0.0006
577 APLASTIC ANAEMIA 3 0.0006
578 SEPSIS 64 0.0006
579 RASH PRURITIC 31 0.0006
580 ASTHENIA 213 0.0006
581 ACUTE RESPIRATORY DISTRESS SYNDROME 10 0.0006
582 SEASONAL ALLERGY 8 0.0006
583 LYMPHADENOPATHY 20 0.0006
584 HEPATIC FUNCTION ABNORMAL 21 0.0006
585 CARDIAC FAILURE 45 0.0006
586 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
587 BRAIN OEDEMA 7 0.0006
588 PULMONARY ARTERIAL HYPERTENSION 8 0.0006
589 OXYGEN SATURATION DECREASED 31 0.0006
590 ASPIRATION 6 0.0005
591 FAECALOMA 3 0.0005
592 TACHYCARDIA 48 0.0005
593 RENAL INJURY 16 0.0005
594 HEPATIC ENCEPHALOPATHY 5 0.0005
595 VISUAL IMPAIRMENT 66 0.0005
596 REBOUND EFFECT 6 0.0005
597 MITRAL VALVE INCOMPETENCE 6 0.0005
598 PULMONARY HYPERTENSION 11 0.0005
599 UVEITIS 7 0.0005
600 SPLENOMEGALY 6 0.0005
601 LYMPHOCYTE COUNT DECREASED 9 0.0005
602 BRADYCARDIA 27 0.0005
603 VITREOUS FLOATERS 5 0.0005
604 DIABETES MELLITUS INADEQUATE CONTROL 9 0.0005
605 CHEST PAIN 93 0.0005
606 SALIVARY HYPERSECRETION 5 0.0005
607 GANGRENE 3 0.0005
608 SENSORY LOSS 4 0.0005
609 MYASTHENIA GRAVIS 4 0.0005
610 FRUSTRATION TOLERANCE DECREASED 4 0.0005
611 HYPERGLYCAEMIA 18 0.0005
612 PNEUMONIA 159 0.0005
613 DECUBITUS ULCER 4 0.0005
614 BODY TEMPERATURE INCREASED 10 0.0005
615 ABDOMINAL DISTENSION 51 0.0005
616 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
617 CHROMATURIA 11 0.0005
618 PALPITATIONS 57 0.0005
619 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
620 VENTRICULAR TACHYCARDIA 8 0.0005
621 CHOLANGITIS 3 0.0005
622 PERITONITIS 10 0.0005
623 COAGULOPATHY 8 0.0005
624 PHOTOPHOBIA 9 0.0005
625 DERMATITIS 10 0.0005
626 PLEURAL EFFUSION 29 0.0005
627 DIARRHOEA 305 0.0005
628 HEMIPARESIS 8 0.0005
629 DYSGEUSIA 35 0.0005
630 CIRCULATORY COLLAPSE 8 0.0005
631 EATING DISORDER 10 0.0005
632 EXPOSURE DURING PREGNANCY 29 0.0005
633 PREMATURE BABY 14 0.0005
634 RESPIRATORY TRACT INFECTION 12 0.0005
635 SYNCOPE 46 0.0005
636 HYPERKALAEMIA 16 0.0005
637 CONDITION AGGRAVATED 138 0.0005
638 ANGINA PECTORIS 13 0.0005
639 PRODUCT COMMUNICATION ISSUE 4 0.0005
640 MUSCULOSKELETAL CHEST PAIN 7 0.0005
641 VISUAL ACUITY REDUCED 15 0.0005
642 OEDEMA PERIPHERAL 55 0.0005
643 INTESTINAL OBSTRUCTION 17 0.0005
644 DEHYDRATION 60 0.0004
645 OBSTRUCTIVE AIRWAYS DISORDER 5 0.0004
646 SKIN INFECTION 5 0.0004
647 TASTE DISORDER 9 0.0004
648 OROPHARYNGEAL DISCOMFORT 4 0.0004
649 GENERAL PHYSICAL CONDITION ABNORMAL 3 0.0004
650 ULCER 7 0.0004
651 PREMATURE DELIVERY 7 0.0004
652 DYSPEPSIA 43 0.0004
653 HEPATIC STEATOSIS 8 0.0004
654 BACTERIAL INFECTION 8 0.0004
655 NEPHROPATHY 4 0.0004
656 OSTEONECROSIS 14 0.0004
657 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
658 DYSPHAGIA 40 0.0004
659 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
660 RASH ERYTHEMATOUS 20 0.0004
661 PULMONARY FIBROSIS 8 0.0004
662 THERAPEUTIC RESPONSE DECREASED 25 0.0004
663 VERTIGO 25 0.0004
664 PHARYNGEAL SWELLING 4 0.0004
665 INFECTION 59 0.0004
666 HYPOAESTHESIA 61 0.0004
667 HYPERCALCAEMIA 5 0.0004
668 PALLOR 11 0.0004
669 PNEUMONITIS 11 0.0004
670 FEELING DRUNK 3 0.0004
671 ORTHOSTATIC HYPOTENSION 7 0.0004
672 PULMONARY OEDEMA 18 0.0004
673 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
674 ABDOMINAL PAIN LOWER 10 0.0004
675 MUSCLE ATROPHY 5 0.0004
676 FEEDING DISORDER 8 0.0004
677 HYPOTENSION 79 0.0004
678 DRUG LEVEL DECREASED 4 0.0004
679 BLINDNESS 16 0.0004
680 EPILEPSY 12 0.0004
681 BOWEL MOVEMENT IRREGULARITY 3 0.0004
682 ADVERSE EVENT 36 0.0004
683 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4 0.0004
684 FOOD ALLERGY 3 0.0004
685 HAEMOLYSIS 3 0.0004
686 OEDEMA 21 0.0004
687 APHTHOUS ULCER 3 0.0004
688 GASTROOESOPHAGEAL REFLUX DISEASE 31 0.0004
689 NERVOUS SYSTEM DISORDER 12 0.0004
690 RHABDOMYOLYSIS 16 0.0004
691 AFFECTIVE DISORDER 3 0.0004
692 FURUNCLE 3 0.0004
693 OBESITY 6 0.0004
694 DRY SKIN 50 0.0004
695 SENSORY DISTURBANCE 6 0.0004
696 HALLUCINATION 28 0.0004
697 VISION BLURRED 51 0.0004
698 BIPOLAR DISORDER 4 0.0004
699 ADVERSE DRUG REACTION 33 0.0004
700 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
701 PERIPHERAL COLDNESS 5 0.0004
702 DRUG LEVEL INCREASED 6 0.0004
703 PRODUCT USE ISSUE 68 0.0004
704 ERUCTATION 7 0.0004
705 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
706 PNEUMONIA ASPIRATION 9 0.0004
707 VENTRICULAR FIBRILLATION 4 0.0004
708 MENTAL STATUS CHANGES 10 0.0004
709 THERAPY NON-RESPONDER 16 0.0004
710 FISTULA 4 0.0004
711 ABDOMINAL DISCOMFORT 59 0.0004
712 ANURIA 3 0.0003
713 SKIN ULCER 9 0.0003
714 PERICARDIAL EFFUSION 8 0.0003
715 FLUID OVERLOAD 5 0.0003
716 BLOOD CALCIUM INCREASED 3 0.0003
717 GROIN PAIN 3 0.0003
718 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 10 0.0003
719 CHOLECYSTITIS 4 0.0003
720 IMMUNODEFICIENCY 5 0.0003
721 ANAL INCONTINENCE 3 0.0003
722 ABDOMINAL PAIN UPPER 68 0.0003
723 FUNGAL INFECTION 11 0.0003
724 BURSITIS 4 0.0003
725 NEURALGIA 8 0.0003
726 INSURANCE ISSUE 5 0.0003
727 TOXICITY TO VARIOUS AGENTS 55 0.0003
728 CHEST DISCOMFORT 33 0.0003
729 APPENDICITIS 3 0.0003
730 ARTERIOSCLEROSIS 3 0.0003
731 POISONING 4 0.0003
732 PARAESTHESIA 50 0.0003
733 CHILLS 37 0.0003
734 MATERNAL EXPOSURE DURING PREGNANCY 28 0.0003
735 HOSPITALISATION 48 0.0003
736 MYDRIASIS 4 0.0003
737 AFFECT LABILITY 3 0.0003
738 HEART RATE IRREGULAR 7 0.0003
739 DIZZINESS POSTURAL 3 0.0003
740 EAR PAIN 6 0.0003
741 DRY MOUTH 25 0.0003
742 EPISTAXIS 23 0.0003
743 URINARY INCONTINENCE 9 0.0003
744 WHEEZING 18 0.0003
745 PULMONARY CONGESTION 4 0.0003
746 UNDERDOSE 22 0.0003
747 INSOMNIA 80 0.0003
748 URINARY RETENTION 10 0.0003
749 CORONARY ARTERY DISEASE 9 0.0003
750 FACE OEDEMA 5 0.0003
751 DRY THROAT 3 0.0003
752 GINGIVAL BLEEDING 4 0.0003
753 ILLNESS 30 0.0003
754 ARTHRALGIA 121 0.0003
755 THROAT IRRITATION 13 0.0003
756 ORAL DISCOMFORT 4 0.0003
757 WOUND 8 0.0003
758 RENAL FAILURE 38 0.0003
759 HYPERSENSITIVITY 53 0.0003
760 HEAD DISCOMFORT 5 0.0003
761 MOVEMENT DISORDER 9 0.0003
762 GALLBLADDER DISORDER 5 0.0003
763 DIZZINESS 139 0.0003
764 RHINORRHOEA 18 0.0003
765 LETHARGY 16 0.0003
766 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
767 FAECES DISCOLOURED 6 0.0003
768 MYELODYSPLASTIC SYNDROME 4 0.0003
769 CHRONIC KIDNEY DISEASE 21 0.0003
770 HYPERTHYROIDISM 4 0.0003
771 DEPRESSION 62 0.0003
772 RASH 118 0.0003
773 LIVER DISORDER 12 0.0003
774 MYALGIA 46 0.0003
775 WHITE BLOOD CELL COUNT DECREASED 29 0.0003
776 RESPIRATORY DISORDER 8 0.0003
777 MUSCULOSKELETAL PAIN 14 0.0003
778 BLISTER 15 0.0003
779 LOSS OF CONSCIOUSNESS 34 0.0003
780 HYPOAESTHESIA ORAL 4 0.0003
781 PROTEINURIA 5 0.0003
782 FATIGUE 204 0.0003
783 PERIPHERAL SWELLING 40 0.0003
784 OROPHARYNGEAL PAIN 24 0.0003
785 TREMOR 43 0.0003
786 MYOCARDIAL INFARCTION 45 0.0003
787 DEATH 222 0.0003
788 EJECTION FRACTION DECREASED 4 0.0003
789 BRAIN FOG 4 0.0003
790 BLOOD IRON DECREASED 3 0.0003
791 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
792 HALLUCINATION, AUDITORY 4 0.0003
793 GASTROINTESTINAL HAEMORRHAGE 21 0.0003
794 DIABETIC KETOACIDOSIS 6 0.0002
795 CARDIAC FAILURE CONGESTIVE 20 0.0002
796 LOCALISED INFECTION 6 0.0002
797 INTENTIONAL SELF-INJURY 5 0.0002
798 ENCEPHALOPATHY 6 0.0002
799 CARDIOMEGALY 3 0.0002
800 HAIR COLOUR CHANGES 3 0.0002
801 AGEUSIA 6 0.0002
802 ACUTE MYOCARDIAL INFARCTION 7 0.0002
803 BACK PAIN 55 0.0002
804 HYPERTENSION 50 0.0002
805 RETCHING 5 0.0002
806 HAEMATURIA 8 0.0002
807 UNRESPONSIVE TO STIMULI 6 0.0002
808 FLATULENCE 13 0.0002
809 BURNING SENSATION 16 0.0002
810 HEART RATE DECREASED 8 0.0002
811 DRUG INEFFECTIVE 299 0.0002
812 ADVERSE REACTION 3 0.0002
813 FEAR 6 0.0002
814 COVID-19 39 0.0002
815 HEADACHE 139 0.0002
816 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
817 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
818 NEPHROLITHIASIS 10 0.0002
819 DYSURIA 8 0.0002
820 FLUID RETENTION 11 0.0002
821 CONSTIPATION 47 0.0002
822 CARDIO-RESPIRATORY ARREST 9 0.0002
823 COORDINATION ABNORMAL 3 0.0002
824 CARPAL TUNNEL SYNDROME 3 0.0002
825 BLOOD TEST ABNORMAL 3 0.0002
826 PRURITUS 82 0.0002
827 BLINDNESS UNILATERAL 3 0.0002
828 STAPHYLOCOCCAL INFECTION 7 0.0002
829 ANXIETY 60 0.0002
830 GASTRIC ULCER 4 0.0002
831 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
832 VIRAL INFECTION 7 0.0002
833 SKIN DISORDER 7 0.0002
834 CARDIOGENIC SHOCK 3 0.0002
835 ACCIDENTAL UNDERDOSE 3 0.0002
836 POST PROCEDURAL COMPLICATION 4 0.0002
837 MENTAL IMPAIRMENT 5 0.0002
838 HAEMORRHOIDS 4 0.0002
839 CHOKING 4 0.0002
840 ORAL HERPES 4 0.0002
841 SINUS DISORDER 4 0.0002
842 DELIRIUM 7 0.0002
843 BLOOD PRESSURE ABNORMAL 4 0.0002
844 MALAISE 88 0.0002
845 PRESCRIBED UNDERDOSE 4 0.0002
846 AGGRESSION 10 0.0002
847 SWELLING FACE 13 0.0002
848 LACRIMATION INCREASED 6 0.0002
849 UNEVALUABLE EVENT 15 0.0002
850 GYNAECOMASTIA 6 0.0002
851 DIPLOPIA 5 0.0002
852 C-REACTIVE PROTEIN INCREASED 7 0.0002
853 CONFUSIONAL STATE 31 0.0002
854 ACCIDENTAL OVERDOSE 7 0.0002
855 CYANOSIS 3 0.0002
856 ARTHRITIS 15 0.0002
857 MOUTH ULCERATION 4 0.0002
858 SINUSITIS 19 0.0002
859 CATARACT 11 0.0002
860 SLEEP DISORDER 13 0.0002
861 CHOLELITHIASIS 6 0.0002
862 MUSCULOSKELETAL STIFFNESS 16 0.0002
863 EYE DISORDER 6 0.0002
864 INFLUENZA LIKE ILLNESS 15 0.0002
865 MELAENA 4 0.0002
866 ERYTHEMA 37 0.0002
867 STEVENS-JOHNSON SYNDROME 4 0.0002
868 CELLULITIS 9 0.0002
869 RASH PAPULAR 4 0.0002
870 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
871 SKIN EXFOLIATION 15 0.0002
872 EYE PAIN 10 0.0002
873 AGITATION 13 0.0002
874 ASTHMA 20 0.0002
875 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
876 ABNORMAL BEHAVIOUR 7 0.0002
877 DISORIENTATION 7 0.0002
878 PRODUCT AVAILABILITY ISSUE 4 0.0002
879 GASTRIC DISORDER 6 0.0002
880 ABORTION SPONTANEOUS 7 0.0002
881 JOINT SWELLING 21 0.0002
882 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
883 MUSCLE TWITCHING 4 0.0002
884 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
885 RASH MACULAR 6 0.0002
886 BLOOD CHOLESTEROL INCREASED 8 0.0002
887 DEVICE USE ISSUE 3 0.0002
888 OSTEOPOROSIS 7 0.0002
889 GOUT 3 0.0002
890 MUSCULAR WEAKNESS 19 0.0002
891 INTERSTITIAL LUNG DISEASE 8 0.0002
892 PANIC ATTACK 6 0.0002
893 URINARY TRACT INFECTION 28 0.0002
894 SUICIDAL IDEATION 15 0.0002
895 BALANCE DISORDER 14 0.0002
896 DEVICE LEAKAGE 7 0.0002
897 DRY EYE 8 0.0002
898 PRODUCT DOSE OMISSION ISSUE 47 0.0002
899 DYSARTHRIA 6 0.0002
900 PAIN IN EXTREMITY 46 0.0002
901 LIP SWELLING 5 0.0001
902 URTICARIA 25 0.0001
903 PAIN OF SKIN 4 0.0001
904 SUICIDE ATTEMPT 9 0.0001
905 ILL-DEFINED DISORDER 9 0.0001
906 HYPERHIDROSIS 19 0.0001
907 NEUTROPHIL COUNT DECREASED 6 0.0001
908 MUSCLE SPASMS 27 0.0001
909 RESPIRATORY ARREST 4 0.0001
910 NIGHTMARE 5 0.0001
911 PROCEDURAL PAIN 4 0.0001
912 ARTHROPATHY 8 0.0001
913 DRUG DEPENDENCE 23 0.0001
914 HEART RATE INCREASED 14 0.0001
915 PAIN IN JAW 4 0.0001
916 RESTLESSNESS 5 0.0001
917 INFLAMMATION 7 0.0001
918 ANGIOEDEMA 6 0.0001
919 EYE SWELLING 5 0.0001
920 ATRIAL FIBRILLATION 13 0.0001
921 DEPRESSED MOOD 7 0.0001
922 ACNE 10 0.0001
923 LIMB DISCOMFORT 4 0.0001
924 HAEMATOCHEZIA 7 0.0001
925 CYSTITIS 4 0.0001
926 INFLUENZA 14 0.0001
927 SOMNOLENCE 25 0.0001
928 DYSKINESIA 5 0.0001
929 CEREBRAL INFARCTION 3 0.0001
930 ALOPECIA 24 0.0001
931 BRONCHITIS 9 0.0001
932 WEIGHT INCREASED 27 0.0001
933 ROAD TRAFFIC ACCIDENT 5 0.0001
934 TYPE 2 DIABETES MELLITUS 4 0.0001
935 DIABETES MELLITUS 9 0.0001
936 OSTEOARTHRITIS 5 0.0001
937 SWELLING 11 0.0001
938 IRRITABILITY 7 0.0001
939 DISCOMFORT 7 0.0001
940 SPEECH DISORDER 6 0.0001
941 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
942 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
943 CEREBROVASCULAR ACCIDENT 19 0.0001
944 COLITIS ULCERATIVE 5 0.0001
945 COMPLETED SUICIDE 9 0.0001
946 CARDIAC DISORDER 10 0.0001
947 COMA 5 0.0001
948 GAIT DISTURBANCE 20 0.0001
949 HERPES ZOSTER 6 0.0001
950 DYSSTASIA 3 0.0001
951 NASAL CONGESTION 6 0.0001
952 DEVICE ISSUE 9 0.0001
953 APHASIA 3 0.0001
954 HAEMORRHAGE 10 0.0001
955 BLOOD PRESSURE INCREASED 14 0.0001
956 MEDICATION ERROR 5 0.0001
957 GAIT INABILITY 3 0.0001
958 NECK PAIN 5 0.0001
959 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
960 ANGER 3 0.0001
961 INCORRECT DOSE ADMINISTERED 20 0.0001
962 FALL 29 0.0001
963 BONE PAIN 5 0.0001
964 SURGERY 5 0.0001
965 BLOOD GLUCOSE DECREASED 4 0.0001
966 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
967 CONTUSION 8 0.0001
968 OVERDOSE 17 0.0001
969 THERAPY CESSATION 4 0.0001
970 AMNESIA 5 0.0001
971 PAIN 47 0.0001
972 NASOPHARYNGITIS 14 0.0001
973 THROMBOSIS 6 0.0001
974 ANAPHYLACTIC REACTION 4 0.0001
975 DRUG DOSE OMISSION BY DEVICE 5 0.0001
976 BLOOD GLUCOSE INCREASED 12 0.0001
977 INFUSION RELATED REACTION 4 0.0001
978 INTENTIONAL PRODUCT MISUSE 5 0.0001
979 DISTURBANCE IN ATTENTION 3 0.0001
980 FEELING ABNORMAL 13 0.0001
981 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
982 FLUSHING 5 0.0000
983 MEMORY IMPAIRMENT 6 0.0000
984 MIGRAINE 4 0.0000
985 DRUG DOSE OMISSION 6 0.0000
986 RHEUMATOID ARTHRITIS 4 0.0000
987 NO ADVERSE EVENT 5 0.0000
988 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 5 0.0000
989 INJECTION SITE PAIN 5 0.0000